medigraphic.com
ISSN 0188-2198 (Print)

2000, Number 2

<< Back Next >>

Rev Mex Cardiol 2000; 11 (2)

Treatment of chronic heart failure

Villalpando GJ, Alcocer DBL, Campos FE, Cardona MEG, Llamas EG, Lozano SH, Necoechea AJC, Rivera CJ

Language: Spanish
References: 33
Page: 239-253
PDF size: 153.91 Kb.


Text Extraction

No abstract


REFERENCES

  1. Cohn JN. The management of chronic heart failure. N Engl J Med 1996; 335: 490-497.

  2. Uretsky BF, Young JB, Shahidi FE et al. Randomized study assessing the effect of digoxin witdrawal in patients with mild to moderate chronic congestive heart failure: Results of the PROVED trial. PROVED Investigative Group. J Am Coll Cardiol 1993; 22: 955-962.

  3. Packer M, Gheorghiade M, Young JB et al: On behalf of the RADIANCE Study: Withdrawal of digoxin from patients with chronic heart failure treated with angiotensin-converting-enzyme inhibitors. N Engl J Med 1993; 329: 1-7.

  4. Guidelines for the evaluation and management of heart failure. Report of the American College of Cardiology/ American Heart Association Task Force on practice guidelines. (Committe on evaluation and management of heart failuer) J Am Coll Cardiol 1995; 26: 1376-1398.

  5. SOLVD Investigators. Effects of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricle ejection fractions. N Engl J Med 1992; 327: 685-691.

  6. 5ª. SOLVD Investigators . Effects of enalapril on survival in patients with reduced left ventricular fractions . and congestive heart failure. N Engl J Med 1991; 325: 293-305.

  7. Pfeffer MA, Braunwald E, Moyé, et al: On behalf of the SAVE Investigators. Effects of captopril on mortality and morbidity in patients with ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. N Engl J Med 1992; 327: 669-677.

  8. GISSI-3: Effects of lisinopril and transdermal glyceryl trinitrate singly and together on 6 week mortality and ventricular function after myocardial infarction. Curr Opin Cardiol 1997;12:407-417.

  9. ISIS-IV: A randomized factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulfate in 58,000 patients with suspected acute myocardial infarction (Fourth International Study of Infarct Survival) Lancet 1995; 345: 669-685.

  10. Cohn JN, Johnson G, Ziesche S et al: A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure (V-HeFT-II). N Engl J Med 1991; 325: 303-310.

  11. Trial Study Group Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). N Engl J Med 1987; 31: 1429-1435.

  12. Acute Infarction Ramipril Efficacy (AIRE) Study Investigators. Effects of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. Lancet 1993;342:821-828.

  13. Cohn JN, Archibald DG, Ziesche S et al: Effects of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative Study (V-HeFT-I). N Engl J Med 1986;314:1547-1552.

  14. Digitalis Investigation Group. The effect of digoxin on mortality and morbidity in patients with heart failure. N Engl J Med 1997;336:525-533.

  15. Packer M, O’Connor CM, Ghali JK, et al: For the Prospective Randomized Amlodipine Survival Evaluation Study Group (PRAISE)) Effects of amlodipine on morbidity and mortality in severe chronic heart failure. N Engl J Med 1996; 335: 1107-1114.

  16. Waagstein F, Hjalmarson A, Varnauskas E. Effect of chronic beta-adrenergic receptors blockade in congestive cardiomyopathy. Br Heart J 1975; 37: 1022-1036.

  17. Waagstein F, Bristow MR, Swedberg K. Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy: Metoprolol in dilated cardiomyopathy (MDC)) Trial Study Group. Lancet 1993; 342: 1441-1446.

  18. CIBIS Investigators and Committees. A randomized trial of beta-blockade in heart failure: The Cardiac Insufficiency Bisoprolol Study (CIBIS). Circulation 1994; 90: 1765-1773.

  19. Randomized trial of low-dose amiodarone in severe congestive heart failure. GESICA Trial. Lancet 1994;344:493-498.

  20. Wenger NK. Assessment of quality of life in clinical of cardiovascular therapies. Le Jacq Publ Inc, 1984

  21. Guyan GH. Measurement of health-related quality of life in heart failure. J Am Coll Cardiol 1993; 22 (Suppl A): 185ª-191ª.

  22. The MDPIT Research Group. Multicenter Diltiazem post infarction group . N Engl J Med 1988; 319: 385-392.

  23. The CAST Investigators. Cardiac Arrythmia suppression trial. N Engl J Med 1989; 321: 406-412.

  24. The German and Austrian xamoterol study group. Double-blind placebo-controlled comparison of digoxin and xamoterol in chronic heart failure. Lancet 1988; 1: 489-493.

  25. Packer M, Carver JR, Rodeheffer RJ, et al: Prospective Randomized Milrinone Survival Evaluation Trial. N Engl J Med 1991; 325: 1468-1475.

  26. Feldman AM, Bristow MR, Parmley WW, et al: Effects of vesnarinone on morbidity and mortality in patients with heart failure. Vesnarinone Study Group. N Engl J Med 1993; 329: 149.155.

  27. Goldourt U, Behar S, Reicher-Reiss H, et al: Early administration of nifedipine in suspected acute myocardial infarction. The Secondary Prevention Reinfarction Israeli Nifedipine Trial II. Arch Intern Med 1993; 153: 345-353.

  28. Cohn JN, Ziesche S, Smith R, et al: Effect of the calcium antagonist felodipine as supplementary vasodilator therapy in patients with chronic heart failure treated with enalapril. V-HeFT-III. Circulation 1997; 96: 856-863.

  29. Packer M, Bristow MR, Cohn JN, et al: US Carvedilol Heart Failure Study. The effect of carvedilolon morbidity and mortality in patients with chronic heart failure. N Engl J Med 1996; 334: 1349-1355.

  30. Pitt b, Segal R, Martínez FA, et al: Randomized trialof Losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in The Elderly study :ELIT). Lancet 1997; 349: 747-752.

  31. Yusuf S, Maggiori AP, Held P, Rouleau JL. Effects of candesartan, enalapril or their combination on exercise capacity, ventricular function , clinical deterioration and quality of life in heart failure: Randomized evaluation of strategies for left ventricular dysfunction. (RESOLVD) Circulation 1997; 96 (Suppl 1): I-452.

  32. CIBIS II Investigators and Committees. The cardiac insufficiency bisoprolol study (CIBIS II). A randomized trial. Lancet 1999; 353: 9-13.

  33. RALES. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. N Engl J Med 1999;341:709-717.




2020     |     www.medigraphic.com